{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:22:51Z","timestamp":1787030571617,"version":"build-2736575974"},"reference-count":44,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.3892\/or.2014.3448","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T08:07:48Z","timestamp":1409213268000},"page":"2150-2158","source":"Crossref","is-referenced-by-count":56,"title":["Reactive oxygen species promote ovarian cancer progression via the HIF-1\u03b1\/LOX\/E-cadherin pathway"],"prefix":"10.3892","volume":"32","author":[{"given":"YU","family":"WANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JUN","family":"MA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAORAN","family":"SHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHENGJIE","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUEPING","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEPHEN B.","family":"HOWELL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XINJIAN","family":"LIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,8,28]]},"reference":[{"key":"key20180107205940_b1-or-32-05-2150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"key20180107205940_b2-or-32-05-2150","article-title":"Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition","author":"Thibault","year":"2013","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107205940_b3-or-32-05-2150","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107205940_b4-or-32-05-2150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1200\/JCO.2007.12.1939","article-title":"Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia","volume":"26","author":"Garcia","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107205940_b5-or-32-05-2150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1200\/JCO.2009.22.7900","article-title":"Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors","volume":"28","author":"Penson","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107205940_b6-or-32-05-2150","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2004.08.028","article-title":"A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer","volume":"95","author":"Berkenblit","year":"2004","journal-title":"Gynecol Oncol"},{"key":"key20180107205940_b7-or-32-05-2150","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20180107205940_b8-or-32-05-2150","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180107205940_b9-or-32-05-2150","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"key20180107205940_b10-or-32-05-2150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180107205940_b11-or-32-05-2150","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res"},{"key":"key20180107205940_b12-or-32-05-2150","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2006.09.042","article-title":"Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment","volume":"127","author":"Anderson","year":"2006","journal-title":"Cell"},{"key":"key20180107205940_b13-or-32-05-2150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.molonc.2008.03.006","article-title":"Molecular aspects of tumour hypoxia","volume":"2","author":"Rademakers","year":"2008","journal-title":"Mol Oncol"},{"key":"key20180107205940_b14-or-32-05-2150","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1128\/MCB.25.15.6415-6426.2005","article-title":"Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1\u03b1","volume":"25","author":"Chan","year":"2005","journal-title":"Mol Cell Biol"},{"key":"key20180107205940_b15-or-32-05-2150","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1242\/jeb.201.8.1153","article-title":"Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression","volume":"201","author":"Ratcliffe","year":"1998","journal-title":"J Exp Biol"},{"key":"key20180107205940_b16-or-32-05-2150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"key":"key20180107205940_b17-or-32-05-2150","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1083\/jcb.200609074","article-title":"The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production","volume":"177","author":"Bell","year":"2007","journal-title":"J Cell Biol"},{"key":"key20180107205940_b18-or-32-05-2150","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1\u03b1 during hypoxia: a mechanism of O2 sensing","volume":"275","author":"Chandel","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107205940_b19-or-32-05-2150","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.freeradbiomed.2005.05.009","article-title":"NO restores HIF-1\u03b1 hydroxylation during hypoxia: role of reactive oxygen species","volume":"39","author":"Callapina","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"key20180107205940_b20-or-32-05-2150","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nature04695","article-title":"Lysyl oxidase is essential for hypoxia-induced metastasis","volume":"440","author":"Erler","year":"2006","journal-title":"Nature"},{"key":"key20180107205940_b21-or-32-05-2150","first-page":"1561","article-title":"Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score","volume":"20","author":"Stewart","year":"2008","journal-title":"Oncol Rep"},{"key":"key20180107205940_b22-or-32-05-2150","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1074\/jbc.M109.042424","article-title":"The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1","volume":"285","author":"Schietke","year":"2010","journal-title":"J Biol Chem"},{"key":"key20180107205940_b23-or-32-05-2150","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1158\/0008-5472.CAN-10-1516","article-title":"The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth","volume":"71","author":"Pez","year":"2011","journal-title":"Cancer Res"},{"key":"key20180107205940_b24-or-32-05-2150","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3892\/ijo.2013.1878","article-title":"Hypoxia inducible factor 1\u03b1-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer","volume":"42","author":"Ji","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107205940_b25-or-32-05-2150","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1158\/0008-5472.CAN-04-4130","article-title":"Differential gene up-regulation by hypoxia-inducible factor-1\u03b1 and hypoxia-inducible factor-2\u03b1 in HEK293T cells","volume":"65","author":"Wang","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107205940_b26-or-32-05-2150","doi-asserted-by":"crossref","first-page":"15215","DOI":"10.1074\/jbc.M511408200","article-title":"Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1\u03b1, HIF-2\u03b1, and other pathways","volume":"281","author":"Elvidge","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180107205940_b27-or-32-05-2150","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.yexcr.2008.03.003","article-title":"The specific contribution of hypoxia-inducible factor-2\u03b1 to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors","volume":"314","author":"Warnecke","year":"2008","journal-title":"Exp Cell Res"},{"key":"key20180107205940_b28-or-32-05-2150","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/jcb.10413","article-title":"Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell","volume":"88","author":"Kagan","year":"2003","journal-title":"J Cell Biochem"},{"key":"key20180107205940_b29-or-32-05-2150","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/jcb.21371","article-title":"Paradoxical roles for lysyl oxidases in cancer - a prospect","volume":"101","author":"Payne","year":"2007","journal-title":"J Cell Biochem"},{"key":"key20180107205940_b30-or-32-05-2150","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1074\/jbc.M609407200","article-title":"Lysyl oxidase interacts with hormone placental lactogen and synergistically promotes breast epithelial cell proliferation and migration","volume":"282","author":"Polgar","year":"2007","journal-title":"J Biol Chem"},{"key":"key20180107205940_b31-or-32-05-2150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10555-007-9062-2","article-title":"Hypoxia-driven selection of the metastatic phenotype","volume":"26","author":"Sullivan","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107205940_b32-or-32-05-2150","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.semcdb.2005.03.007","article-title":"Hypoxia-induced dedifferentiation of tumor cells - a mechanism behind heterogeneity and aggressiveness of solid tumors","volume":"16","author":"Axelson","year":"2005","journal-title":"Semin Cell Dev Biol"},{"key":"key20180107205940_b33-or-32-05-2150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"key20180107205940_b34-or-32-05-2150","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0002-9440(10)63501-8","article-title":"Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells","volume":"163","author":"Imai","year":"2003","journal-title":"Am J Pathol"},{"key":"key20180107205940_b35-or-32-05-2150","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1158\/0008-5472.CAN-05-2670","article-title":"Regulation of E-cadherin expression by VHL and hypoxia-inducible factor","volume":"66","author":"Esteban","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107205940_b36-or-32-05-2150","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1158\/0008-5472.CAN-05-3719","article-title":"Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B","volume":"66","author":"Krishnamachary","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107205940_b37-or-32-05-2150","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1038\/sj.emboj.7600781","article-title":"A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression","volume":"24","author":"Peinado","year":"2005","journal-title":"EMBO J"},{"key":"key20180107205940_b38-or-32-05-2150","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.7314\/APJCP.2012.13.5.2003","article-title":"Association of reduced immunohistochemical expression of E-cadherin with a poor ovarian cancer prognosis - results of a meta-analysis","volume":"13","author":"Peng","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180107205940_b39-or-32-05-2150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1593\/neo.07754","article-title":"Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis","volume":"10","author":"Cai","year":"2008","journal-title":"Neoplasia"},{"key":"key20180107205940_b40-or-32-05-2150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.critrevonc.2008.01.012","article-title":"New therapies for ovarian cancer: cytotoxics and molecularly targeted agents","volume":"67","author":"Dinh","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180107205940_b41-or-32-05-2150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2008.02.028","article-title":"Reactive oxygen species and HIF-1 signalling in cancer","volume":"266","author":"Galanis","year":"2008","journal-title":"Cancer Lett"},{"key":"key20180107205940_b42-or-32-05-2150","first-page":"4478","article-title":"A molecular role for lysyl oxidase in breast cancer invasion","volume":"62","author":"Kirschmann","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107205940_b43-or-32-05-2150","doi-asserted-by":"crossref","first-page":"30271","DOI":"10.1074\/jbc.M202647200","article-title":"Sustained production of H2O2 activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases\/phosphatidylinositol 3-kinase\/NF-\u03baB pathway","volume":"277","author":"Yoon","year":"2002","journal-title":"J Biol Chem"},{"key":"key20180107205940_b44-or-32-05-2150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.amjsurg.2004.11.031","article-title":"Lysyl oxidase expression in bronchogenic carcinoma","volume":"189","author":"Woznick","year":"2005","journal-title":"Am J Surg"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3448\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T16:08:55Z","timestamp":1650038935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,28]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,8,28]]},"published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.3892\/or.2014.3448"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3448","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,28]]}}}